Incyte News

JMP Securities Maintains Incyte(INCY.US) With Hold Rating

Moomoo NewsAug 19 01:32 ET

Analysts Offer Insights on Healthcare Companies: Incyte (INCY) and Cochlear Limited (OtherCHEOF)

TipRanksAug 18 11:52 ET

Incyte's Niktimvo Faces Market Challenges Despite FDA Approval: Analyst Upholds Hold Rating

TipRanksAug 16 04:31 ET

Incyte Analyst Ratings

BenzingaAug 15 10:05 ET

TD Cowen Maintains Incyte(INCY.US) With Buy Rating, Maintains Target Price $80

Moomoo NewsAug 15 08:31 ET

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Incyte (INCY) and Gilead Sciences (GILD)

TipRanksAug 15 07:44 ET

BMO Capital Maintains Incyte(INCY.US) With Sell Rating, Maintains Target Price $48

Moomoo NewsAug 15 07:31 ET

RBC Capital Reaffirms Their Hold Rating on Incyte (INCY)

TipRanksAug 15 06:31 ET

RBC Capital Maintains Incyte(INCY.US) With Hold Rating, Raises Target Price to $67

Moomoo NewsAug 15 06:31 ET

Wells Fargo Adjusts Price Target on Incyte to $63 From $61, Maintains Equalweight Rating

MT NewswiresAug 12 09:33 ET

Incyte (INCY) Gets a Hold From Wells Fargo

TipRanksAug 12 07:22 ET

Incyte Corporation: Revised Earnings and Cautious Hold Rating Amid Unforeseen Financial Commitment

TipRanksAug 7 02:06 ET

Stifel Maintains Incyte(INCY.US) With Hold Rating, Raises Target Price to $73

Moomoo NewsAug 1 22:31 ET

Stifel Nicolaus Sticks to Their Hold Rating for Incyte (INCY)

TipRanksAug 1 22:13 ET

Incyte Price Target Raised to $60.00/Share From $55.00 by Deutsche Bank

Dow JonesAug 1 14:10 ET

Incyte Analyst Ratings

BenzingaAug 1 14:03 ET

Deutsche Bank Adjusts Incyte Price Target to $60 From $55, Maintains Hold Rating

MT NewswiresAug 1 08:52 ET

Argus Adjusts Price Target on Incyte to $75 From $70

MT NewswiresAug 1 08:36 ET

Analysts Offer Insights on Healthcare Companies: Incyte (INCY), Terns Pharmaceuticals (TERN) and Stryker (SYK)

TipRanksAug 1 03:56 ET

Incyte's Strong Product Performance and Growth Trajectory Merit a Buy Rating

TipRanksAug 1 02:09 ET